page_content='primarily include AI-focused shared R&D activities, including development costs of our general AI models; corporate \ninitiatives such as our philanthropic activities; corporate shared costs such as certain finance, human resource, and \nlegal costs, including certain fines and settlements. Charges associated with reductions in our workforce and office \nspace during 2023 were not allocated to our segments. Additionally, hedging gains (losses) related to revenue are \nnot allocated to our segments.\nOther Income (Expense), Net\nThe following table presents our other income (expense), net (in millions; unaudited):\nQuarter Ended December 31,\n2022 2023\nInterest income $ 659 $ 1,110 \nInterest expense  (90)  (69) \nForeign currency exchange gain (loss), net  (185)  (449) \nGain (loss) on debt securities, net  (176)  (115) \nGain (loss) on equity securities, net(1) (1,487)  586 \nPerformance fees  193  (45) \nIncome (loss) and impairment from equity method investments, net  (31)  (256)' metadata={'source': '2023q4-alphabet-earnings-release.pdf', 'page': 7}